Cholinergic denervation in idiopathic rapid eye movement sleep behaviour disorder patients.
Cholinergic dysfunction appears to play a role in the cognitive impairment observed in Parkinson disease (PD) and Dementia with Lewy bodies (DLB). The occurrence of cholinergic dysfunction in the early stages of these conditions, however, has not been investigated. The objective of this study was to investigate cholinergic function in patients with idiopathic rapid eye movement sleep behaviour disorder (iRBD), a disorder recognised to be an early stage of both PD and DLB. Twenty-one polysomnography-confirmed iRBD patients with no evidence of parkinsonism and cognitive impairment and ten controls underwent PET to assess brain acetylcholinesterase levels (11 C-donepezil PET) and nigrostriatal dopaminergic function (18 F-DOPA PET). Clinical examination included MDS-Unified Parkinson Disease Rating Scale part III, Mini Mental State Examination, and Montreal Cognitive Assessment. 11 C-donepezil PET was successfully performed in 17 iRBD patients and 9 controls. Compared to controls, iRBD patients showed a mean 7.65% reduction in neocortical 11 C-donepezil levels (p=0.005). Bilateral superior temporal cortex, occipital cortex, cingulate cortex and dorsolateral prefrontal cortex showed the most significant reductions at voxel level. Reduced neocortical 11 C-donepezil binding in our patients indicates cholinergic denervation and suggests that the projections from the nucleus basalis of Meynert, which supplies cholinergic innervation to the neocortex, are dysfunctional in iRBD. Longitudinal studies will clarify if these changes are predictive of future cognitive impairment in these patients.